Research workspace · registry aware
A pipeline-guided workspace for molecular characterization, evidence exchange, and reproducible research reporting.
Cancer Discovery Pipeline
Seven-stage research frameworkPipelines
The seven stages define the intended scientific journey. They do not indicate that an analysis has run or that every stage is implemented.
Cancer Discovery Pipeline
Each stage must preserve provenance and carry evidence forward through typed contracts.
Data
Register compatible research datasets, access conditions, and provenance before analysis.
Molecular state
Characterize molecular features and frame reproducible state-level analyses.
Biomarkers
Prioritize candidate signals while preserving their source evidence and limitations.
Vulnerabilities
Evaluate research hypotheses against declared functional-dependency contracts.
Pharmacology
Connect candidate hypotheses to registered response evidence when records exist.
Validation
Assess independent evidence and validation gates without overstating readiness.
Report
Assemble traceable records from immutable releases and artifact envelopes.
Manifest sequence
Ordering follows the catalog dependency graph, not a hard-coded project list.
Research-only molecular-state modeling project with independently versioned task contracts. T001 includes metadata and read-only compatibility validation for the completed legacy TCGA-BRCA TP53 candidate. The current platform specification remains unapproved and cannot pass G0 or produce a release.
ConsumesNo upstream artifact types declared
ProducesFeatureEvidence@2.0.0, MolecularSignature@2.0.0, MolecularStatePrediction@1.0.0
Contract scaffold for integrating molecular-state evidence with functional, pharmacological, and proteomic evidence to evaluate candidate vulnerabilities. No vulnerability analysis or validation is implemented.
ConsumesFeatureEvidence@2.0.0, MolecularSignature@2.0.0
ProducesCandidateVulnerability, DrugResponseEvidence, FunctionalDependency, ProteinValidationEvidence
